Navigation Links
Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements
Date:6/2/2008

xample newly diagnosed, is scheduled to start in 2009," explains Dr. Karl-Hermann Schlingensiepen, Chief Executive Officer of Antisense Pharma.

Literature

(1) Bogdahn, U. et al. "Results of a Phase IIb Active-controlled Study with AP 12009 for Patients with Recurrent or Refractory Anaplastic Astrocytoma", ASCO Annual Meeting, 2008, Abstract ID 2076

(2) Bogdahn, U. et al. "Targeted Therapy with AP 12009 in Recurrent or Refractory Glioblastoma Patients: Results of a Phase IIb Study", ASCO Annual Meeting, 2008, Abstract ID 2018

The Phase IIb study AP 12009-G004

The Phase IIb study AP 12009-G004 is an open-label, randomized, active-controlled, parallel-group dose-finding study to evaluate the efficacy and safety of two doses of AP 12009 in adult patients with recurrent or refractory high-grade glioma. Efficacy endpoints were tumor response assessed by central blinded MRI reading and survival. At 29 international clinical centers, 134 evaluable patients (39 with anaplastic astrocytoma, AA, WHO grade III and 95 with glioblastoma, GBM, WHO grade IV) have been randomized to three arms: AP 12009 10 mM, AP 12009 80 mM and standard chemotherapy (Temozolomide or PCV) as an active control. AP 12009 was administered intratumorally via one catheter as continuous high-flow microperfusion over a 7-day period every other week for up to 6 months on an outpatient treatment basis. Tumor response was assessed according to Macdonald criteria. Post-study follow-up for survival, long-term tumor response, and safety is still ongoing. Analysis of the core phase is completed.

High-Grade Glioma

Anaplastic astrocytoma and glioblastoma are the two most common forms of primary brain tumors, a diagnosis with high unmet medical need. Adults as well as children may be affected, although the age peak is at 45-65 years. Current therapies comprise surgery, radiation and/or chemotherapy. Despite recent advances, the prognosis for these patients is still po
'/>"/>

SOURCE Antisense Pharma GmbH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
2. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
3. New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting
4. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
5. Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting
6. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
7. BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
8. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
9. Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO
10. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
11. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... LEHIGH VALLEY, Pa. , July 7, 2015  Air ... efficiency of its medical oxygen supply systems—including high efficiency systems ... the 52 nd ASHE Annual Conference and Technical Exhibition ... ASHE attendees are invited to stop by ... help reduce their oxygen usage by as much as 30 ...
(Date:7/7/2015)... , June 30, 2015 ... of the "Outlook of Global Biologic Drug Discovery ... The global biologic drug discovery outsourcing market will likely ... 2020, and may reach $11.4 B by 2020. ... biologics (or biopharmaceuticals) have become a new but important ...
(Date:7/7/2015)... , July 7, 2015 Biobanks ... Helping Your Influence  ,Are you interested ... so, now gain technological and commercial predictions from 2015. ... explore trends in research and development, results, opportunities and ... visiongain shows you what,s possible for biobanking and ...
Breaking Medicine Technology:Air Products Highlights Reliability and Efficiency of Its Medical Oxygen Supply Systems at ASHE Conference and Exhibition 2Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 2Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 2Biobanking for Medicine: Technology, Industry and Market 2015-2025 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 4Biobanking for Medicine: Technology, Industry and Market 2015-2025 5Biobanking for Medicine: Technology, Industry and Market 2015-2025 6Biobanking for Medicine: Technology, Industry and Market 2015-2025 7Biobanking for Medicine: Technology, Industry and Market 2015-2025 8Biobanking for Medicine: Technology, Industry and Market 2015-2025 9Biobanking for Medicine: Technology, Industry and Market 2015-2025 10
(Date:7/7/2015)... ... July 07, 2015 , ... ... announced the CelestixEdge VE and CelestixFederated VA Series virtual appliances. These virtual ... Series portfolio of products, which have proven to simplify the on-premises deployment of ...
(Date:7/7/2015)... ... ... At the end of June Pacific Prime Renewals team in Hong Kong announced that ... the Renewals Manager, Danielle Cotton, aims to not only reduce but eventually eliminate the use ... “We send anything between 300 and 600 pieces of paper per month. Not to mention ...
(Date:7/7/2015)... ... 07, 2015 , ... On Saturday, May 16th, 2015, the Manistee, MI chapter ... Country Club. Best Drug Rehabilitation staff members were delighted to join in for this ... International, the parent of the Manistee Kiwanis Club, is a global organization that works ...
(Date:7/7/2015)... ... July 07, 2015 , ... With a new community program ... with Soldiers’ Angels and announced a new charity campaign to raise funds in support ... of Soldiers’ Angels, which was created especially to care for the special needs of ...
(Date:7/7/2015)... Horsham, PA (PRWEB) , ... July 07, 2015 ... ... seasoned financial executive Ellen Purdy as the company’s new Chief Financial Officer, effective ... financial and leadership experience in companies ranging from a multi-billion dollar, global chemical ...
Breaking Medicine News(10 mins):Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 2Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 3Health News:Office Practicum Announces new CFO 2
... Cambridge, Mass. - May 21, 2012 - Environmental scientists ... mercury, a toxic element, is caused by both atmospheric ... the element north into the Arctic Ocean. While ... that twice as much mercury actually comes from the ...
... ATS 2012, SAN FRANCISCO Troublesome dyspnea that limits ... according to a new study from Denmark. "We ... older patients with severe COPD or heart failure, both ... Ejvind Frausing Hansen, MD, chief physician at Hvidovre Hospital ...
... Washington, DC Rising prices for care were the chief ... in 2010, according to the first report from the ... capita spending on inpatient and outpatient facilities, professional procedures, ... beneficiaries under age 65 with private, employer-sponsored group insurance. ...
... FRIDAY, May 18 (HealthDay News) -- The U.S. Centers for Disease ... -- the baby boom generation -- tested for hepatitis C. ... group, and most were infected in their teens and 20s and ... this as an unrecognized health crisis and we needed to take ...
... Madison, Wis. and San Francisco Sleep-disordered breathing (SDB), ... increased risk of cancer mortality, according to a new ... increased risks of hypertension, cardiovascular disease, depression, and early ... apnea with higher rate of cancer mortality. Lead author ...
... of Seattle Children,s Hospital, and colleagues conducted a study to ... exacerbations in children younger than 6 years of age with ... for patients 6 years or older with CF, but its ... years. In the randomized trial, the active treatment group ...
Cached Medicine News:Health News:Toxic mercury, accumulating in the Arctic, springs from a hidden source 2Health News:Toxic mercury, accumulating in the Arctic, springs from a hidden source 3Health News:Toxic mercury, accumulating in the Arctic, springs from a hidden source 4Health News:Troublesome dyspnea during sexual activity is common in COPD patients 2Health News:Report using private health claims data shows prices are driving health spending growth 2Health News:Report using private health claims data shows prices are driving health spending growth 3Health News:Report using private health claims data shows prices are driving health spending growth 4Health News:Test Baby Boomers for Hepatitis C, Says CDC 2Health News:UW study: Sleep apnea associated with higher mortality from cancer 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: